Business Description
Panacea Biotec is an Indian biotechnology company founded in 1984 and headquartered in New Delhi, with products sold across roughly 50 countries. The company develops and manufactures a wide range of vaccines targeting diseases such as dengue, typhoid, hepatitis A, and COVID-19, alongside prescription medicines covering areas like cancer care, diabetes, and pain management. It also sells children's nutritional products under its ChilRun brand family and holds interests in real estate. The company works with partners including the Russian Direct Investment Fund and the Indian Council of Medical Research to advance its vaccine development programs.
